Press Releases

Sep 14, 2020

FDA grants Dupixent® (dupilumab) Breakthrough Therapy designation for eosinophilic esophagitis

* Designation based on positive results from Part A of pivotal Phase 3 trial
Sep 9, 2020

Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020

- New data on investigational brain-penetrant BTK inhibitor tolebrutinib (SAR442168) further support its potential in modulating disabling inflammatory processes within the central nervous system
Sep 8, 2020

Biopharma leaders unite to stand with science

- Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines
Sep 3, 2020

Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMO
Aug 17, 2020

Sanofi to acquire Principia Biopharma

* Further strengthens core R&D areas of autoimmune and allergic diseases

Show per page